FDA to restrict GLP‑1 ingredients used in non‑approved compounded drugs

Hims & Hers Health +0.99% Pre

Hims & Hers Health

HIMS

21.36

21.50

+0.99%

+0.66% Pre

- The U.S. Food and Drug Administration on Friday said it plans to restrict GLP-1 ingredients used in non-approved compounded drugs that companies such as Hims & Hers HIMS.N and other compounding pharmacies have been marketing as alternatives to authorized treatments, citing concerns over quality, safety and potential violations of federal law.